{"schema_version":"secwatch.filing_event.v1","accession":"0001801170-22-000006","form_type":"8-K","ticker":"CLOV","cik":"0001801170","company_name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","filed_at":"2022-01-19T23:59:59+00:00","discovered_at":"2026-05-14T18:04:08.281042+00:00","generated_at":"2026-06-27T17:15:53.969714+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Clover Health General Counsel Gia Lee steps down; Karen Soares named Interim GC","bullets":["Gia Lee, General Counsel, steps down effective Jan 19, 2022; Karen Soares named Interim General Counsel.","Lee receives separation payments: $520k (12 months base salary + prior year bonus), $120k (2021 bonus), $700k special cash bonus for de-SPAC work.","During 12-month consulting period, Lee gets $10k/month and continued stock option vesting; she may terminate consulting at any time.","Departure not due to any disagreement; CEO Vivek Garipalli thanked Lee for her contributions."],"urls":{"canonical":"https://secwatch.observer/filing/0001801170-22-000006","json":"https://secwatch.observer/filing/0001801170-22-000006.json","markdown":"https://secwatch.observer/filing/0001801170-22-000006.md","text":"https://secwatch.observer/filing/0001801170-22-000006.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1801170/000180117022000006/0001801170-22-000006-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1801170/000180117022000006/clov-20220113.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T17:15:53.969714+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"a7458c299a","claim":"Gia Lee departed as General Counsel at CLOVER HEALTH INVESTMENTS, CORP. /DE.","evidence_excerpt":"Gia Lee, the Company’s General Counsel, will be stepping down as an officer of the Company today.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1801170/000180117022000006/0001801170-22-000006-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"stepping down"},{"label":"Role","value":"General Counsel"}],"fact_type":"executive_change"},{"claim_id":"ce76d9e1b4","claim":"Karen Soares was appointed as Interim General Counsel at CLOVER HEALTH INVESTMENTS, CORP. /DE.","evidence_excerpt":"Effective on January 19, 2022, and until a permanent replacement for Ms. Lee has been named, Karen Soares, the Company’s Deputy General Counsel, will serve as the Company’s Interim General Counsel.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1801170/000180117022000006/0001801170-22-000006-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Interim General Counsel"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}